Donate online today. €375 funds the helpline for half a day

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

Scientific Version


Page(s): 1 2 3 4 5  Next 5  

Does B and T cell function of adults predict a poor response to the C conjugate meningococcal vaccine?

HPA Vaccine Evaluation Department, London, UK, University of Sheffield, Sheffield, UK

From UK efficacy data, and from our own work in which we have measured responses to C polysaccharide challenge amongst recipients of the meningococcal C conjugate vaccine (MCC), it is concluded...


Impact of the UK pneumococcal conjugate vaccine programme on pneumococcal genetics and disease manifestations.

HPA Centre for Infections, London, UK

The 7-valent pneumococcal conjugate vaccine (PNC-7) will be introduced into the UK infant vaccination programme in 2006. Following the introduction of the vaccine in the US in 2001 the number of...


Improving the early recognition of meningitis and septicaemia in children and adolescents.

Oxford University, Oxford, UK

Identifying children with meningococcal disease in primary care is challenging. Children may present in the early stages of the disease, before typical symptoms are apparent. In addition, although...


Locating the structural and immunological basis for protection of a new MenB recombinant vaccine.

National Institute for Biological Standards and Control, Hertfordshire, UK

A study of the structural and in vivo and in vitro pre-clinical immunology of a recombinant outer membrane protein vaccine developed at Chiron Vaccines is to be carried out at the National Institute...


Meningitis-associated hearing loss: protection against cochlear neuronal damage by adjunctive therapy with neurotrophins.

Klinikum Grosshadern Ludwig Maximilians University, Munich, Germany

One of the most common long term residues in survivors of bacterial meningitis is the development of hearing loss, which affects up to 30%.


The identification of novel immunomodulatory factors from Neisseria meningitidis serogroup B.

Trinity College, Dublin, Ireland

Neisseria meningitidis serogroup B is a major cause of bacterial meningitis and fatal septicaemia. The bacterium colonises the upper nasopharynx of a considerable proportion of the human population...


Page(s): 1 2 3 4 5  Next 5  
Search research projects
Joe Wilson
Meningococcal disease
Meningococcal disease at 2

The nurse told me Joe must have been incubating this for days.

More stories
Meet us on Facebook